Koyfin Home > Directory > Health Care > Intercept Pharmaceuticals > Long-Term Debt / Capital

Intercept Pharmaceuticals Long-Term Debt / Capital Chart (ICPT)

Intercept Pharmaceuticals annual/quarterly Long-Term Debt / Capital from 2016 to 2020.
  • Intercept Pharmaceuticals Long-Term Debt / Capital for the quarter ending June 06, 2020 was $115m a 30.95% increase of 36m year over year
  • Intercept Pharmaceuticals Long-Term Debt / Capital for the last 12 months ending June 06, 2020 was $115m a 30.95% increase of 36m year over year
  • Intercept Pharmaceuticals Annual Long-Term Debt / Capital for 2019 was $90m a -5.29% decrease of -5m from 2018
  • Intercept Pharmaceuticals Annual Long-Term Debt / Capital for 2018 was $95m a -0.52% decrease of 0m from 2017
  • Intercept Pharmaceuticals Annual Long-Term Debt / Capital for 2017 was $96m a 45.59% increase of 44m from 2016
Other Ratios Metrics:
  • Intercept Pharmaceuticals Total Debt / Capital for the quarter ending September 09, 2018 was $71m a -34.16% decrease of -24m year over year
  • Intercept Pharmaceuticals Other Liabilities for the quarter ending September 09, 2018 was $5m a -50.16% decrease of -3m year over year
  • Intercept Pharmaceuticals Total Debt / Equity for the quarter ending September 09, 2018 was $248m a -27.17% decrease of -67m year over year
View Chart On Koyfin

Quarterly ICPT Long-Term Debt / Capital Data

06/2020$115m
03/2020$105m
12/2019$90m
09/2019$80m
06/2019$75m
03/2019$114m
12/2018$95m
09/2018$79m
06/2018$71m
03/2018$117m

Annual ICPT Long-Term Debt / Capital Data

2019$90m
2018$95m
2017$96m
2016$52m
2010$1m